4DMedical (ASX:4DX) reported Friday fiscal first-half loss of AU$0.259 per share, widening from a loss of AU$0.025 a year earlier.
Revenue for the six months ended Dec. 31, 2025, was AU$2.9 million, compared with AU$2.9 million a year earlier. Analysts surveyed by FactSet expected AU$3 million.
The board continues to not recommend or declare a dividend.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.